-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Applied Genetic Technologies Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2015 to Q3 2022.
- Applied Genetic Technologies Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000.
- Applied Genetic Technologies Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2022 was $0.000.
- Applied Genetic Technologies Corp annual Income Tax Expense (Benefit) for 2022 was $0.000.
- Applied Genetic Technologies Corp annual Income Tax Expense (Benefit) for 2021 was -$2.11M, a 2640% decline from 2020.
- Applied Genetic Technologies Corp annual Income Tax Expense (Benefit) for 2020 was $83K, a 9.21% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)